Direkt zum Inhalt
Merck
  • MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.

Cancer medicine (2017-04-26)
Nengquan Sheng, Gewen Tan, Weiqiang You, Hongqi Chen, Jianfeng Gong, Di Chen, Huizhen Zhang, Zhigang Wang
ZUSAMMENFASSUNG

MicroRNA-145 (miR-145), as a tumor-suppressive miRNA, has been demonstrated down-regulated in colorectal cancer (CRC) cells, and could inhibit CRC cells growth. However, the molecular pathway in which miR-145 modulates CRC malignant transformation has not been fully revealed. Here, we reported an intense correlation between the expressions of PAK4 and miR-145 in human CRC cell lines. Transwell assay verified overexpression of miR-145, as well as knockdown of PAK4, significantly suppressed cell migration and invasion ability. The impaired migration and invasion ability of SW1116 cells was affected through the down-regulation of phosphorylation level of LIMK1 and cofilin in a PAK4-dependent manner. Collectively, we have demonstrated that miR-145 suppressed CRC migration and invasion through PAK4 pathway, which provides an attractive microRNA-based therapeutic target for CRC.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-15-Medium (Leibovitz), With L-glutamine, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
McCoy 5A-Medium, Modified, with L-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell culture